Loading
Latest filing published 05 Aug 2026 for 명문제약.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
양환태, listed as senior executive, appears in our data through filings on 명문제약 shares, published by DART (FSS). Over a trading history stretching from 28 April 2026 to 5 August 2026, the count stands at 3 filings.
Purchases make up the whole of the open-market record (3 purchases). The totals do not cover 3 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The latest filing, published on 5 August 2026, reports an open-market purchase in 명문제약. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.